Citations (196)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Atukuri Dorababu. (2023) Update of Recently (2016–2020) Designed Azepine Analogs and Related Heterocyclic Compounds with Potent Pharmacological Activities. Polycyclic Aromatic Compounds 43:3, pages 2250-2268.
Read now
Read now
Om Prakash Singh & Shyam Sundar. (2022) Visceral leishmaniasis elimination in India: progress and the road ahead. Expert Review of Anti-infective Therapy 20:11, pages 1381-1388.
Read now
Read now
Priscila Goes Camargo, Bruna Taciane da Silva Bortoleti, Marcieli Fabris, Manoela Daiele Gonçalves, Fernanda Tomiotto-Pellissier, Idessania Nazareth Costa, Ivete Conchon-Costa, Camilo Henrique da Silva Lima, Wander Rogério Pavanelli, Marcelle de Lima Ferreira Bispo & Fernando Macedo Jr. (2022) Thiohydantoins as anti-leishmanial agents: n vitro biological evaluation and multi-target investigation by molecular docking studies. Journal of Biomolecular Structure and Dynamics 40:7, pages 3213-3222.
Read now
Read now
Bilal Zulfiqar & Vicky. M. Avery. (2022) Assay development in leishmaniasis drug discovery: a comprehensive review. Expert Opinion on Drug Discovery 17:2, pages 151-166.
Read now
Read now
Leandro da Costa Clementino, Fernando Bombarda Oda, Thaiz Rodrigues Teixeira, Renata Spagolla Napoleão Tavares, Pio Colepicolo, André Gonzaga dos Santos, Hosana Maria Debonsi & Márcia A. S. Graminha. (2021) The antileishmanial activity of the antarctic brown alga Ascoseira mirabilis Skottsberg. Natural Product Research 35:23, pages 5470-5474.
Read now
Read now
Catarina de Souza, Janicy A. Carvalho, Alexandro S. Abreu, Lucas P. de Paiva, Jéssica A. R. Ambrósio, Milton Beltrame Junior, Marco A. de Oliveira, Josane Mittmann & Andreza R. Simioni. (2021) Polyelectrolytic gelatin nanoparticles as a drug delivery system for the promastigote form of Leishmania amazonensis treatment. Journal of Biomaterials Science, Polymer Edition 32:1, pages 1-21.
Read now
Read now
Juliana Q. Reimão, Débora P. Pita Pedro & Adriano C. Coelho. (2020) The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history. Expert Opinion on Drug Discovery 15:6, pages 647-658.
Read now
Read now
Cristina de Castro Spadari, Fernanda Walt Mendes da Silva de Bastiani, Luciana Biagini Lopes & Kelly Ishida. (2019) Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis. International Journal of Nanomedicine 14, pages 5187-5199.
Read now
Read now
Juliane S. Lanza, Sébastien Pomel, Philippe M. Loiseau & Frédéric Frézard. (2019) Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases. Expert Opinion on Drug Delivery 16:10, pages 1063-1079.
Read now
Read now
Jaya Chakravarty & Shyam Sundar. (2019) Current and emerging medications for the treatment of leishmaniasis. Expert Opinion on Pharmacotherapy 20:10, pages 1251-1265.
Read now
Read now
Shyam Sundar, Jaya Chakravarty & Lalit P Meena. (2019) Leishmaniasis: treatment, drug resistance and emerging therapies. Expert Opinion on Orphan Drugs 7:1, pages 1-10.
Read now
Read now
Naiara Maran, Pollyanna Stephanie Gomes, Leonardo Freire-de-Lima, Elisangela Oliveira Freitas, Célio Geraldo Freire-de-Lima & Alexandre Morrot. (2016) Host resistance to visceral leishmaniasis: prevalence and prevention. Expert Review of Anti-infective Therapy 14:4, pages 435-442.
Read now
Read now
Articles from other publishers (184)
Rabia Fatima, Sammer Yousuf & M. Iqbal Choudhary. (2024) Cocrystallization of methyltestosterone with salicylic acid and 2,2′-disulfanediyldibenzoic acid - Effect on solubility of methyltestosterone and growth of leishmania parasite (amastigotes and promastigotes). Journal of Molecular Structure 1295, pages 136741.
Crossref
Crossref
Jéssica Adriana Jesus, Thays Nicolli Fragoso da Silva, Ilza Maria Oliveira Sousa, Aurea Favero Ferreira, Márcia Dalastra Laurenti, Paulo Cardoso da Costa, Domingos de Carvalho Ferreira & Luiz Felipe Domingues Passero. (2023) Nanostructured Lipid Carriers as Robust Systems for Lupeol Delivery in the Treatment of Experimental Visceral Leishmaniasis. Pharmaceuticals 16:12, pages 1646.
Crossref
Crossref
Sarah Kymberly Santos de Lima, Ítalo Novaes Cavallone, Dolores Remedios Serrano, Brayan J. Anaya, Aikaterini Lalatsa, Márcia Dalastra Laurenti, João Henrique Ghilardi Lago, Dalete Christine da Silva Souza, Gabriela Pustiglione Marinsek, Beatriz Soares Lopes, Renata de Britto Mari & Luiz Felipe Domingues Passero. (2023) Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis. Pharmaceutics 15:11, pages 2602.
Crossref
Crossref
Cristina de Castro Spadari, Luana Pereira Borba-Santos, Sonia Rozental & Kelly Ishida. (2023) Miltefosine repositioning: A review of potential alternative antifungal therapy.. Journal of Medical Mycology, pages 101436.
Crossref
Crossref
Camila S. Freitas, Samira S. Santiago, Daniela P. Lage, Luciana M.R. Antinarelli, Fabrício M. Oliveira, Danniele L. Vale, Vívian T. Martins, Lícia N.D. Magalhaes, Raquel S. Bandeira, Fernanda F. Ramos, Isabela A.G. Pereira, Marcelo M. de Jesus, Fernanda Ludolf, Grasiele S.V. Tavares, Adilson V. Costa, Rafaela S. Ferreira, Elaine S. Coimbra, Róbson R. Teixeira & Eduardo A.F. Coelho. (2023) In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis. Experimental Parasitology 251, pages 108555.
Crossref
Crossref
Rhuane Coutinho Afonso, Raíssa Mara Kao Yien, Luciana Betzler de Oliveira de Siqueira, Naomi Kato Simas, Ana Paula dos Santos Matos & Eduardo Ricci-Júnior. (2023) Promising natural products for the treatment of cutaneous leishmaniasis: A review of in vitro and in vivo studies. Experimental Parasitology 251, pages 108554.
Crossref
Crossref
Vitor Luca Moura Marmo, Jéssica A. R. Ambrósio, Erika Peterson Gonçalves, Leandro José Raniero, Milton Beltrame Junior, Juliana G. Pinto, Juliana Ferreira-Strixino & Andreza R. Simioni. (2023) Vaterite microparticle-loaded methylene blue for photodynamic activity in macrophages infected with Leishmania braziliensis. Photochemical & Photobiological Sciences 22:8, pages 1977-1989.
Crossref
Crossref
Cynthia Demicheli, Virgínia M. R. Vallejos, Juliane S. Lanza, Guilherme S. Ramos, Bruno R. Do Prado, Sébastien Pomel, Philippe M. Loiseau & Frédéric Frézard. (2023) Supramolecular assemblies from antimony(V) complexes for the treatment of leishmaniasis. Biophysical Reviews.
Crossref
Crossref
Janaina Fernandes. (2023) Virus-Induced Lysis of Tumor and Other Pathogenic Unicellular Entities and Its Potential to Treat Leishmaniasis. DNA and Cell Biology 42:6, pages 305-314.
Crossref
Crossref
Ganesh Yadagiri, Aakriti Singh, Kanika Arora & Shyam Lal Mudavath. (2023) Immunotherapy and immunochemotherapy in combating visceral leishmaniasis. Frontiers in Medicine 10.
Crossref
Crossref
Jéseka G. Schirmann, Bruna T. S. Bortoleti, Manoela D. Gonçalves, Fernanda Tomiotto-Pellissier, Priscila G. Camargo, Milena M. Miranda-Sapla, Camilo H. S. Lima, Marcelle L. F. Bispo, Idessania N. Costa, Ivete Conchon-Costa, Wander R. Pavanelli, Robert F. H. Dekker & Aneli M. Barbosa-Dekker. (2023) In-vitro biological evaluation of 3,3′,5,5′-tetramethoxy-biphenyl-4,4′-diol and molecular docking studies on trypanothione reductase and Gp63 from Leishmania amazonensis demonstrated anti-leishmania potential. Scientific Reports 13:1.
Crossref
Crossref
Carlos García-Estrada, Yolanda Pérez-Pertejo, Bárbara Domínguez-Asenjo, Vanderlan Nogueira Holanda, Sankaranarayanan Murugesan, María Martínez-Valladares, Rafael Balaña-Fouce & Rosa M. Reguera. (2023) Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates. Biomolecules 13:4, pages 637.
Crossref
Crossref
Helena Tuszewska, Jacek Szczepański, Sławomir Mandziuk & Nazar Trotsko. (2023) Thiazolidin-4-one-based derivatives – Efficient tools for designing antiprotozoal agents. A review of the last decade. Bioorganic Chemistry 133, pages 106398.
Crossref
Crossref
Tauane G. Soyer, Fernanda F. Ramos, Isabela A. G. Pereira, Daniela P. Lage, Raquel S. Bandeira, Marcelo M. de Jesus, Guilherme P. Costa, Amanda S. Machado, Camila S. Freitas, Danniele L. Vale, Vívian T. Martins, Alexsandro S. Galdino, Miguel A. Chávez-Fumagalli, Daniel Menezes-Souza, Mariana C. Duarte, Bruno M. Roatt, Eduardo A. F. Coelho & Grasiele S. V. Tavares. (2023) Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis. Pathogens 12:2, pages 314.
Crossref
Crossref
Shumaila Naz, Aiman Aroosh, Ayse Caner, Esra Atalay Şahar, Seray Toz, Yusuf Ozbel & Sumra Wajid Abbasi. (2023) Immunoinformatics Approach to Design a Multi-Epitope Vaccine against Cutaneous Leishmaniasis. Vaccines 11:2, pages 339.
Crossref
Crossref
Deepak Gupta, Pankaj K. Singh, Pavan K. Yadav, Tadigoppula Narender, Umesh K. Patil, Sanjay K. Jain & Manish K. Chourasia. (2023) Emerging strategies and challenges of molecular therapeutics in antileishmanial drug development. International Immunopharmacology 115, pages 109649.
Crossref
Crossref
Estela Melcon-Fernandez, Giulio Galli, Carlos García-Estrada, Rafael Balaña-Fouce, Rosa M. Reguera & Yolanda Pérez-Pertejo. (2023) Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis. International Journal of Molecular Sciences 24:2, pages 1635.
Crossref
Crossref
Veena Sreedharan & K.V. Bhaskara Rao. (2023) Protease inhibitors as a potential agent against visceral Leishmaniasis: A review to inspire future study. The Brazilian Journal of Infectious Diseases 27:1, pages 102739.
Crossref
Crossref
Nabendu Biswas & Labonya Mandal. 2023. Viral, Parasitic, Bacterial, and Fungal Infections. Viral, Parasitic, Bacterial, and Fungal Infections
383
388
.
Santanu Ghosh, Nabanita Kar & Mousumi Das. 2023. Viral, Parasitic, Bacterial, and Fungal Infections. Viral, Parasitic, Bacterial, and Fungal Infections
449
465
.
Ankita Rani, Shilpika Khanikar, Mukul Dutta, Shivani Katiyar, Tooba Qamar, Anuradha Seth, P K Agnihotri, Rajdeep Guha, Jai N Vishwakarma & Susanta Kar. (2022)
Quinolinyl β-enaminone derivatives exhibit leishmanicidal activity against
Leishmania donovani
by impairing the mitochondrial electron transport chain complex and inducing ROS-mediated programmed cell death
. Journal of Antimicrobial Chemotherapy.
Crossref
Crossref
Jinying Gu, Qiuyu Wu, Qiuyue Zhang, Qidong You & Lei Wang. (2022) A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives. European Journal of Medicinal Chemistry 243, pages 114742.
Crossref
Crossref
Shobha Kumari, Vikash Kumar, Ritesh Kumar Tiwari, Vidyanand Ravidas, Krishna Pandey & Ashish Kumar. (2022) Amphotericin B: A drug of choice for Visceral Leishmaniasis. Acta Tropica 235, pages 106661.
Crossref
Crossref
Florentina Daraban Bocaneti, Larisa Maria Ivanescu, Liviu Miron, Oana Irina Tanase & Mihaela Anca Dascalu. (2022) An Overview on Leishmaniasis in Romania: Diagnosis and Therapeutics. Tropical Medicine and Infectious Disease 7:11, pages 334.
Crossref
Crossref
Patrícia Severino, Wanessa Santana, Erika S. Lisboa, Victoria L. S. dos Santos, Erica T. dos Santos Lima, Juliana C. Cardoso, Ricardo L. C. de Albuquerque-Junior, Beatriz C. Naveros, Antonello Santini, Eliana B. Souto & Sona Jain. (2022) Cutaneous/Mucocutaneous Leishmaniasis Treatment for Wound Healing: Classical versus New Treatment Approaches. Microbiology Research 13:4, pages 836-852.
Crossref
Crossref
Kaio Maciel de Santiago-Silva, Bruna Taciane da Silva Bortoleti, Laudicéa do Nascimento Oliveira, Fernanda Lima de Azevedo Maia, Joyce Cristina Castro, Ivete Conchon Costa, Danielle Bidóia Lazarin, James L. Wardell, Solange M. S. V. Wardell, Magaly Girão Albuquerque, Camilo Henrique da Silva Lima, Wander Rogério Pavanelli, Marcelle de Lima Ferreira Bispo & Raoni Schroeder B. Gonçalves. (2022) Antileishmanial Activity of 4,8-Dimethoxynaphthalenyl Chalcones on Leishmania amazonensis. Antibiotics 11:10, pages 1402.
Crossref
Crossref
Brian Okundaye, Neha Biyani, Samrat Moitra & Kai Zhang. (2022) The Golgi-localized sphingosine-1-phosphate phosphatase is indispensable for Leishmania major. Scientific Reports 12:1.
Crossref
Crossref
Sara Scarpini, Arianna Dondi, Camilla Totaro, Carlotta Biagi, Fraia Melchionda, Daniele Zama, Luca Pierantoni, Monia Gennari, Cinzia Campagna, Arcangelo Prete & Marcello Lanari. (2022) Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics. Microorganisms 10:10, pages 1887.
Crossref
Crossref
Debora B. Scariot, Austeja Staneviciute, Jennifer Zhu, Xiaomo Li, Evan A. Scott & David M. Engman. (2022) Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Julio Abel Alfredo dos Santos Simone Come, Yibin Zhuang, Tianzhen Li, Simone Brogi, Sandra Gemma, Tao Liu & Edson Roberto da Silva. (2022) In Vitro and In Silico Analyses of New Cinnamid and Rosmarinic Acid-Derived Compounds Biosynthesized in Escherichia coli as Leishmania amazonensis Arginase Inhibitors. Pathogens 11:9, pages 1020.
Crossref
Crossref
Romain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, Sébastien Hutter, Alix Sournia-Saquet, Clotilde Boudot, Emilie Brenot, Caroline Castera-Ducros, Sophie Corvaisier, Marc Since, Aurélie Malzert-Fréon, Bertrand Courtioux, Alexis Valentin, Pierre Verhaeghe, Nadine Azas, Pascal Rathelot & Patrice Vanelle. (2022) Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial Pharmacophore. Pharmaceuticals 15:8, pages 998.
Crossref
Crossref
Carlos J. Bethencourt-Estrella, Samuel Delgado-Hernández, Atteneri López-Arencibia, Desirée San Nicolás-Hernández, David Tejedor, Fernando García-Tellado, Jacob Lorenzo-Morales & José E. Piñero. (2022) In vitro activity and cell death mechanism induced by acrylonitrile derivatives against Leishmania amazonensis. Bioorganic Chemistry 124, pages 105872.
Crossref
Crossref
Janine Aucamp & David D. N’Da. (2022) In vitro antileishmanial efficacy of antiplasmodial active aminoquinoline-chalcone hybrids. Experimental Parasitology 236-237, pages 108249.
Crossref
Crossref
Somenath Roy Chowdhury, Subhendu K. Das, Bijoylaxmi Banerjee, Srijita Paul Chowdhuri, Hemanta K. Majumder & Benu Brata Das. (2022)
TDP1 knockout
Leishmania donovani
accumulate topoisomerase 1‐linked DNA damage and are hypersensitive to clinically used antileishmanial drugs
. The FASEB Journal 36:4.
Crossref
Crossref
Manoj Kumar Singh, Arpita Das, Rudra P Saha, Joydeep Paul & Debkumar Nandi. (2022) Leishmaniasis: Plants as a source of antileishmanial agents. Journal of Experimental Biology and Agricultural Sciences 10:1, pages 227-247.
Crossref
Crossref
Marta H. Branquinha, Pedro S. S. Araújo, Simone S. C. Oliveira, Leandro S. Sangenito, Diego S. Gonçalves, Sérgio H. Seabra, Claudia M. d’Avila-Levy & André L. S. Santos. (2022) Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B. Tropical Medicine and Infectious Disease 7:2, pages 29.
Crossref
Crossref
Nuchpicha Intakhan, Padet Siriyasatien & Wetpisit Chanmol. (2022) Anti-Leishmania activity of artesunate and combination effects with amphotericin B against Leishmania (Mundinia) martiniquensis in vitro. Acta Tropica 226, pages 106260.
Crossref
Crossref
Débora Cristina de Oliveira Silva Nunes, Mônica Soares Costa, Luiz Borges Bispo-da-Silva, Eloísa Amália Vieira Ferro, Mariana Alves Pereira Zóia, Luiz Ricardo Goulart, Renata Santos Rodrigues, Veridiana de Melo Rodrigues & Kelly Aparecida Geraldo Yoneyama. (2022) Mitochondrial dysfunction on Leishmania (Leishmania) amazonensis induced by ketoconazole: insights into drug mode of action. Memórias do Instituto Oswaldo Cruz 117.
Crossref
Crossref
Sauman Singh-Phulgenda, Sumayyah Rashan, Eli Harriss, Prabin Dahal, Caitlin Naylor, Matthew Brack, Philippe J. Guerin & Brittany J. Maguire. (2022) Infectious diseases data observatory (IDDO) visceral leishmaniasis library of clinical therapeutic studies: A protocol for a living systematic review of clinical studies. Wellcome Open Research 7, pages 155.
Crossref
Crossref
Bruna Taciane da Silva Bortoleti, Manoela Daiele Gonçalves, Fernanda Tomiotto-Pellissier, Priscila Goes Camargo, João Paulo Assolini, Virginia Marcia Concato, Mariana Barbosa Detoni, Danielle Larazin Bidóia, Marcelle de Lima Ferreira Bispo, Camilo Henrique da Silva Lima, Fernando Cesar de MacedoJr.Jr., Ivete Conchon-Costa, Milena Menegazzo Miranda-Sapla, Pryscilla Fanini Wowk & Wander Rogério Pavanelli. (2022) Investigation of the antileishmanial activity and mechanisms of action of acetyl-thiohydantoins. Chemico-Biological Interactions 351, pages 109690.
Crossref
Crossref
Julián Medina, Lissa Cruz-Saavedra, Luz Helena Patiño, Marina Muñoz & Juan David Ramírez. (2021) Comparative analysis of the transcriptional responses of five Leishmania species to trivalent antimony. Parasites & Vectors 14:1.
Crossref
Crossref
Arezki Izri, Amina Bendjaballah-Laliam, Denis Sereno, Ihcene Kherachi Djenad, Zoubir Harrat & Mohammad Akhoundi. (2021) Amputation of a type II diabetic patient with cutaneous leishmaniasis due to Leishmania major. BMC Infectious Diseases 21:1.
Crossref
Crossref
Leandro da Costa Clementino, Guilherme Felipe Santos Fernandes, Igor Muccilo Prokopczyk, Wilquer Castro Laurindo, Danyelle Toyama, Bruno Pereira Motta, Amanda Martins Baviera, Flávio Henrique-Silva, Jean Leandro dos Santos & Marcia A. S. Graminha. (2021) Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity. PLOS ONE 16:11, pages e0259008.
Crossref
Crossref
Diksha Kumari, Summaya Perveen, Rashmi Sharma & Kuljit Singh. (2021) Advancement in leishmaniasis diagnosis and therapeutics: An update. European Journal of Pharmacology 910, pages 174436.
Crossref
Crossref
Patrick O. Sakyi, Richard K. Amewu, Robert N. O. A. Devine, Emahi Ismaila, Whelton A. Miller & Samuel K. Kwofie. (2021) The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade. Natural Products and Bioprospecting 11:5, pages 489-544.
Crossref
Crossref
Atul TripathiAmber Vyas. (2021) In-vitro evaluation of nano-liposomal formulation of Fluconazole and Amphotericin B against visceral leishmaniasis. Research Journal of Pharmacy and Technology, pages 4929-4933.
Crossref
Crossref
Nargis Shaheen, Chaitenya Verma, Thalia Pacheco-Fernandez, Greta Volpedo, Aneeqa Hamid, Ismail Zeb, Syed Aizaz Ali Shah, Shah Fahad, Attiya Iqbal, Asma Ashraf, Amjad Khan, Misbah Gul, Muhammad Ilyas Khan, Huma Fatima, Muhammad Afzal, Abhay R Satoskar & Naveeda Akhter Qureshi. (2021) Molecular characterization and genetic diversity of cutaneous leishmaniasis from North Eastern Pakistan. Acta Tropica 221, pages 105964.
Crossref
Crossref
Gurpreet Kaur, Kalpana Chauhan, Namrata Anand & Sukhbir Kaur. (2021) Evaluation of In vitro and In vivo Protective Efficacy of Bauhinia variegata Against Leishmania donovani in Murine Model. Acta Parasitologica 66:3, pages 812-826.
Crossref
Crossref
Thaila Fernanda dos Reis, Maria Augusta Crivelente Horta, Ana Cristina Colabardini, Caroline Mota Fernandes, Lilian Pereira Silva, Rafael Wesley Bastos, Maria Vitória de Lazari Fonseca, Fang Wang, Celso Martins, Márcio L. Rodrigues, Cristina Silva Pereira, Maurizio Del Poeta, Koon Ho Wong & Gustavo H. Goldman. (2021) Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine. mBio 12:4.
Crossref
Crossref
Bárbara Domínguez-Asenjo, Camino Gutiérrez-Corbo, María Álvarez-Bardón, Yolanda Pérez-Pertejo, Rafael Balaña-Fouce & Rosa M. Reguera. (2021) Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis. ACS Infectious Diseases 7:8, pages 2390-2401.
Crossref
Crossref
Simone SC Oliveira, Carine S Ferreira, Marta H Branquinha, André LS Santos, Marco V Chaud, Sona Jain, Juliana C Cardoso, Anđelka B Kovačević, Eliana B Souto & Patrícia Severino. (2020) Overcoming multi‐resistant leishmania treatment by nanoencapsulation of potent antimicrobials. Journal of Chemical Technology & Biotechnology 96:8, pages 2123-2140.
Crossref
Crossref
Ahmed Abdelhameed, Mei Feng, April C. Joice, Emilia M. Zywot, Yiru Jin, Chris La Rosa, Xiaoping Liao, Heidi L. Meeds, Yena Kim, Junan Li, Craig A. McElroy, Michael Zhuo Wang & Karl A. Werbovetz. (2021) Synthesis and Antileishmanial Evaluation of Arylimidamide–Azole Hybrids Containing a Phenoxyalkyl Linker. ACS Infectious Diseases 7:7, pages 1901-1922.
Crossref
Crossref
Anh Minh Thao Nguyen, Skye Brettell, Noélie Douanne, Claudia Duquette, Audrey Corbeil, Emanuella F. Fajardo, Martin Olivier, Christopher Fernandez-Prada & William D. Lubell. (2021) Influence of N-Methylation and Conformation on Almiramide Anti-Leishmanial Activity. Molecules 26:12, pages 3606.
Crossref
Crossref
Aurora Diotallevi, Gloria Buffi, Giovanni Corbelli, Marcello Ceccarelli, Margherita Ortalli, Stefania Varani, Mauro Magnani & Luca Galluzzi. (2021) In Vitro Reduced Susceptibility to Pentavalent Antimonials of a Leishmania infantum Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy. Microorganisms 9:6, pages 1147.
Crossref
Crossref
Héctor Serrano-Coll, Ana Pilar Ramos, Nora Cardona-Castro & Alejandro Llanos-Cuentas. (2021) Leishmaniasis cutánea: una mirada a la clínica, diagnóstico y tratamiento de esta enigmática enfermedad. Piel 36:5, pages 317-324.
Crossref
Crossref
Donald J. AbrahamConor R. Caffrey, Dietmar Steverding, Rafaela S. Ferreira, Renata B. Oliveira, Anthony J. O'Donoghue, Ludovica Monti, Carlo Ballatore, Kelly A. Bachovchin, Lori Ferrins, Michael P. Pollastri, Kimberley M. Zorn, Daniel H. Foil, Alex M. Clark, Melina Mottin, Carolina H. Andrade, Jair L. Siqueira‐Neto & Sean Ekins. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
79
.
Diana J Garay-Baquero, David E Rebellón-Sánchez, Miguel D Prieto, Lina Giraldo-Parra, Adriana Navas, Sheryl Atkinson, Stuart McDougall & Maria Adelaida Gómez. (2021) Inductively coupled plasma mass spectrometry method for plasma and intracellular antimony quantification applied to pharmacokinetics of meglumine antimoniate. Bioanalysis.
Crossref
Crossref
Sauman Singh-Phulgenda, Prabin Dahal, Roland Ngu, Brittany J. Maguire, Alice Hawryszkiewycz, Sumayyah Rashan, Matthew Brack, Christine M. Halleux, Fabiana Alves, Kasia Stepniewska, Piero L Olliaro & Philippe J. Guerin. (2021) Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis. PLOS Neglected Tropical Diseases 15:3, pages e0009302.
Crossref
Crossref
Mohsen Mohammadi, Amin Moradi Hasan-Abad, Parva Dehghani, Iraj Nabipour, Mona Roozbehani, Andrew Hemphill, Marzieh Taherzadeh, Mohammad Ali Mohaghegh & Moradali Fouladvand. (2020) Dicentracin-Like from Asian sea bass Fish and Moronecidine-Like from Hippocampus Comes: Two Candidate Antimicrobial Peptides Against Leishmanina major Infection. International Journal of Peptide Research and Therapeutics 27:1, pages 769-778.
Crossref
Crossref
Audrey Silva, Amanda Costa, Sona Jain, Eduardo Coelho, Ricardo Fujiwara, Ricardo Scher, Rogéria Nunes & Silvio Dolabella. (2021) Application of Poloxamers for the Development of Drug Delivery System to Treat Leishmaniasis: A Review. Current Drug Targets 22:3, pages 296-309.
Crossref
Crossref
Izak F. Prinsloo, Nonkululeko H. Zuma, Janine Aucamp & David D. N’Da. (2020) Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives. Chemical Biology & Drug Design 97:2, pages 383-398.
Crossref
Crossref
Guilherme S. Ramos, Virgínia M.R. Vallejos, Marina S. Ladeira, Priscila G. Reis, Daniel M. Souza, Yuri A. Machado, Luiz O. Ladeira, Maurício B.V. Pinheiro, Maria N. Melo, Ricardo T. Fujiwara & Frédéric Frézard. (2021) Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis. Biomedicine & Pharmacotherapy 134, pages 111120.
Crossref
Crossref
Ana Flávia Borges, Juliana D'Andrea Molina & Marilda Aparecida Milanez Morgado de Abreu. (2021) Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment. Revista da Sociedade Brasileira de Medicina Tropical 54.
Crossref
Crossref
Beatriz Maria de Almeida Braz, Raizza Barros Sousa Silva, Suzanna Cavalcante Lins, Diego Ricardo Xavier Silva, Walter Massa Ramalho & Marcia Almeida de Melo. (2021) Demographic and spatial study of visceral leishmaniasis in the state of Alagoas, Brazil, during 2007-2018. Revista da Sociedade Brasileira de Medicina Tropical 54.
Crossref
Crossref
Christina Hadjiaggelidou, Chrysanthi Vadikolia, Evgenia Verrou, Efthalia Yiannaki, Theodora Triantafyllou, Vasiliki Palaska, Konstantina Keramidioti, Kyriaki Tsirou, Asimina PapanikolaouDimitra Markala, Pavlina Konstantinidou & Eirini Katodritou. (2021) Visceral Leishmaniasis in 2 Patients Treated With Lenalidomide and Dexamethasone: A Possible Correlation With Blunted Immune Response. HemaSphere 5:1, pages e506.
Crossref
Crossref
Lokesh Kumar Tripathi & Tapan Kumar Nailwal. 2021. Pathogenesis, Treatment and Prevention of Leishmaniasis. Pathogenesis, Treatment and Prevention of Leishmaniasis
1
25
.
José Peña-Guerrero, Joan Puig-Rigall, Gustavo González-Gaitano & Paul Nguewa. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases
253
290
.
Cristina de Castro Spadari, Taissa Vila, Vinícius de Morais Barroso & Kelly Ishida. 2021. Encyclopedia of Mycology. Encyclopedia of Mycology
456
467
.
Wanessa T. Clemente & Paulo H. O. Mourão. 2021. Emerging Transplant Infections. Emerging Transplant Infections
1341
1371
.
Igor A. Rodrigues, Andreza R. Garcia, Mariana M. Paz, Rogério G. D. Grilo Junior, Ana Claudia F. Amaral & Anderson S. Pinheiro. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
143
180
.
Vanderlan Nogueira Holanda, Welson Vicente da Silva, Pedro Henrique do Nascimento, Sérgio Ruschi Bergamachi Silva, Paulo Euzébio Cabral Filho, Shalom Porto de Oliveira Assis, César Augusto da Silva, Ronaldo Nascimento de Oliveira, Regina Celia Bressan Queiroz de Figueiredo & Vera Lucia de Menezes Lima. (2020) Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: In silico ADMET, in vitro activity, docking and molecular dynamic simulations. Bioorganic Chemistry 105, pages 104437.
Crossref
Crossref
Manar Madah, Shaden Haddad & Mays Khazem. (2020) Evaluation of the effect of Peganum harmala extracts on the in vitro viability of Leishmania tropica promastigotes in comparison to Glucantime. Journal of Parasitic Diseases 44:4, pages 858-863.
Crossref
Crossref
Abdrrahman S. Surur, Abebaw Fekadu, Eyasu Makonnen & Asrat Hailu. (2020) Challenges and Opportunities for Drug Discovery in Developing Countries: The Example of Cutaneous Leishmaniasis. ACS Medicinal Chemistry Letters 11:11, pages 2058-2062.
Crossref
Crossref
Mónica Galocha, Inês Vieira Costa & Miguel Cacho Teixeira. (2020) Carrier-Mediated Drug Uptake in Fungal Pathogens. Genes 11:11, pages 1324.
Crossref
Crossref
Paloma Wetler Meireles, Dandara Paiva Barroso de Souza, Marianne Grilo Rezende, Maria Paula Gonçalves Borsodi, Douglas Escrivani de Oliveira, Luiz Cláudio Rodrigues Pereira da Silva, Alessandra Mendonça Teles de Souza, Gil Mendes Viana, Carlos Rangel Rodrigues, Flavia Almada do Carmo, Valeria Pereira de Sousa, Bartira Rossi-Bergmann & Lucio Mendes Cabral. (2020) Nanoparticles Loaded with a New Thiourea Derivative: Development and In vitro Evaluation Against Leishmania amazonensis. Current Drug Delivery 17:8, pages 694-702.
Crossref
Crossref
Aikaterini Lalatsa, Larry Statts, Jéssica Adriana de Jesus, Olivia Adewusi, Maria Auxiliadora Dea-Ayuela, Francisco Bolas-Fernandez, Marcia Dalastra Laurenti, Luiz Felipe Domingues Passero & Dolores R. Serrano. (2020) Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis. International Journal of Pharmaceutics 588, pages 119734.
Crossref
Crossref
João Paulo Assolini, Thais Peron da Silva, Bruna Taciane da Silva Bortoleti, Manoela Daiele Gonçalves, Fernanda Tomiotto-Pellissier, Claudia Stoeglehner Sahd, Amanda Cristina Machado Carloto, Paulo Emilio Feuser, Arthur Poester Cordeiro, Claudia Sayer, Pedro Henrique Hermes de Araújo, Idessania Nazareth Costa, Ivete Conchon-Costa, Milena Menegazzo Miranda-Sapla & Wander Rogério Pavanelli. (2020) 4-nitrochalcone exerts leishmanicidal effect on L. amazonensis promastigotes and intracellular amastigotes, and the 4-nitrochalcone encapsulation in beeswax copaiba oil nanoparticles reduces macrophages cytotoxicity. European Journal of Pharmacology 884, pages 173392.
Crossref
Crossref
Hollis D. Showalter. (2020) Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases. Molecules 25:18, pages 4137.
Crossref
Crossref
Raissa Couto Santana, Alice dos Santos Rosa, Michelle Hipólito da Silva Mateus, Deivid Costa Soares, Georgia Atella, Anderson Cavalcante Guimarães, Antonio Carlos Siani, Monica Freiman S. Ramos, Elvira Maria Saraiva & Lucia H. Pinto-da-Silva. (2020) In vitro leishmanicidal activity of monoterpenes present in two species of Protium (Burseraceae) on Leishmania amazonensis. Journal of Ethnopharmacology 259, pages 112981.
Crossref
Crossref
M. Van den Kerkhof, D. Mabille, S. Hendrickx, P. Leprohon, C. E. Mowbray, S. Braillard, M. Ouellette, L. Maes & G. Caljon. (2020) Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance. Antimicrobial Agents and Chemotherapy 64:9.
Crossref
Crossref
Pankaj Kumar Singh, Bapi Gorain, Hira Choudhury, Sachin Kumar Singh, Pankaj Whadwa, Shilpa, Sanjeev Sahu, Monica Gulati & Prashant Kesharwani. (2020) Macrophage targeted amphotericin B nanodelivery systems against visceral leishmaniasis. Materials Science and Engineering: B 258, pages 114571.
Crossref
Crossref
Pone K. Boniface, Cinthya M. Sano & Ferreira I. Elizabeth. (2020) Unveiling the Targets Involved in the Quest of Antileishmanial Leads Using In silico Methods. Current Drug Targets 21:7, pages 681-712.
Crossref
Crossref
A.P.S. Matos, A.L. Viçosa, M.I. Ré, E. Ricci-Júnior & C. Holandino. (2020) A review of current treatments strategies based on paromomycin for leishmaniasis. Journal of Drug Delivery Science and Technology 57, pages 101664.
Crossref
Crossref
Nima Razzaghi-Asl, Saghi Sepehri, Ahmad Ebadi, Pari Karami, Negin Nejatkhah & Mohammad Johari-Ahar. (2019) Insights into the current status of privileged N-heterocycles as antileishmanial agents. Molecular Diversity 24:2, pages 525-569.
Crossref
Crossref
Cristina de Castro Spadari, Fernanda Wirth, Luciana Biagini Lopes & Kelly Ishida. (2020) New Approaches for Cryptococcosis Treatment. Microorganisms 8:4, pages 613.
Crossref
Crossref
Regina Maia de Souza, Raul Cavalcante Maranhão, Elaine Rufo Tavares, Fabíola Branco Filippin-Monteiro, Antônio Carlos Nicodemo, Aleksandra Tiemi Morikawa, Edite Hatsumi Yamashiro Kanashiro & Valdir Sabbaga Amato. (2019) Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis. Drug Delivery and Translational Research 10:2, pages 403-412.
Crossref
Crossref
Amal Elarabi, Zinab Saad, Walid Saadawi, Nadia Aldobea & Fauzi Sagher. (2022) A rare encounter in nonsuspecting circumstances: First congenital visceral leishmaniasis (kala-azar) in Libya. Ibnosina Journal of Medicine and Biomedical Sciences 12:01, pages 44-48.
Crossref
Crossref
V Ramesh, Keerti Kaumudee Dixit, Neha Sharma, Ruchi Singh & Poonam Salotra. (2020) Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis. The Journal of Infectious Diseases 221:4, pages 608-617.
Crossref
Crossref
Nuchpicha Intakhan, Wetpisit Chanmol, Pradya Somboon, Michelle D. Bates, Vanessa Yardley, Paul A. Bates & Narissara Jariyapan. (2020) Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against Leishmania martiniquensis In Vitro. Pathogens 9:1, pages 49.
Crossref
Crossref
Letícia Figueiredo Cunha, Camila Marques Costa, Poliana Ribeiro Barroso, Kelly Cristina Kato, Fabrício de Oliveira, Carlos Victor Mendonça Filho, Cristiane Fernanda Fuzer Grael, Luiz Elídio Gregório, Fernanda Fraga Campos, Patrícia Machado de Oliveira, Danilo Bretas de Oliveira, Fernando Armini Ruela & Helen Rodrigues Martins. (2020) Phytochemical screening and biological assays of ethanolic leaf extract of Senna rugosa. Rodriguésia 71.
Crossref
Crossref
Amro Ahmad. (2020) Epidemiology and spatiotemporal analysis of visceral leishmaniasis in Palestine from 1990 to 2017. International Journal of Infectious Diseases 90, pages 206-212.
Crossref
Crossref
Ahmed Abdelhameed, Xiaoping Liao, Craig A. McElroy, April C. Joice, Liva Rakotondraibe, Junan Li, Carla Slebodnick, Pu Guo, W. David Wilson & Karl A. Werbovetz. (2020) Synthesis and antileishmanial evaluation of thiazole orange analogs. Bioorganic & Medicinal Chemistry Letters 30:1, pages 126725.
Crossref
Crossref
Wanessa T. Clemente & Paulo H. O. Mourão. 2020. Emerging Transplant Infections. Emerging Transplant Infections
1
31
.
Indira Singh Chauhan, G. Subba Rao & Neeloo Singh. (2019) Enhancing the copy number of Ldrab6 gene in Leishmania donovani parasites mediates drug resistance through drug‐thiol conjugate dependent multidrug resistance protein A (MRPA). Acta Tropica 199, pages 105158.
Crossref
Crossref
Eleni Sioriki, Sylvain Gaillard, Fady Nahra, Rehan Imad, Khair Ullah, Sheeba Wajid, Danish Sharif, Sharmeen Fayyaz, Fiza Arshad, M. Iqbal Choudhary & Steven P. Nolan. (2019) Investigating the Biological Activity of Imidazolium Aurate Salts. ChemistrySelect 4:37, pages 11061-11065.
Crossref
Crossref
Shyam SundarAnup SinghNeha Agrawal & Jaya Chakravarty. (2019) Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar. The American Journal of Tropical Medicine and Hygiene 101:4, pages 795-798.
Crossref
Crossref
Alberta Serwah Anning, Godwin Kwakye-Nuako, Elvis Ofori Ameyaw, Mba-Tihssommah Mosore & Kwame Kumi Asare. (2019) In vitro activity of Erythrophleum ivorense extract against the promastigote stage of cutaneous Leishmania parasite, a member of Leishmania (Mundinia) enriettii complex isolates from Ghana. Access Microbiology 1:7.
Crossref
Crossref
Gurpreet Kaur, Kalpana Chauhan & Sukhbir Kaur. (2019) Lupeol induces immunity and protective efficacy in a murine model against visceral leishmaniasis. Parasitology 146:11, pages 1440-1450.
Crossref
Crossref
Pau Bosch-Nicolau, Maria Ubals, Fernando Salvador, Adrián Sánchez-Montalvá, Gloria Aparicio, Alba Erra, Pablo Martinez de Salazar, Elena Sulleiro & Israel Molina. (2019) Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression. PLOS Neglected Tropical Diseases 13:8, pages e0007708.
Crossref
Crossref
Rosa M. Reguera, Yolanda Pérez-Pertejo, Camino Gutiérrez-Corbo, Bárbara Domínguez-Asenjo, César Ordóñez, Carlos García-Estrada, María Martínez-Valladares & Rafael Balaña-Fouce. (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure and Applied Chemistry 91:8, pages 1385-1404.
Crossref
Crossref
Zahra Mojallal-Tabatabaei, Parham Foroumadi, Mahsa Toolabi, Fereshteh Goli, Setareh Moghimi, Sussan Kaboudanian-Ardestani & Alireza Foroumadi. (2019) 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action. Bioorganic & Medicinal Chemistry 27:16, pages 3682-3691.
Crossref
Crossref
Asli Bilgic-Temel, Dedee F. Murrell & Soner Uzun. (2019) Cutaneous leishmaniasis: A neglected disfiguring disease for women. International Journal of Women's Dermatology 5:3, pages 158-165.
Crossref
Crossref
Driele Peixoto & Daniel P. Prestes. (2019) Parasitic Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient, Including Toxoplasmosis and Strongyloidiasis. Infectious Disease Clinics of North America 33:2, pages 567-591.
Crossref
Crossref
Tauane G. Soyer, Débora V.C. Mendonça, Grasiele S.V. Tavares, Daniela P. Lage, Daniel S. Dias, Patrícia A.F. Ribeiro, Luisa Perin, Fernanda Ludolf, Vinicio T.S. Coelho, Andreza C.G. Ferreira, Pedro H.A.S. Neves, Guilherme F. Matos, Miguel A. Chávez-Fumagalli, Elaine S. Coimbra, Guilherme R. Pereira, Eduardo A.F. Coelho & Luciana M.R. Antinarelli. (2019) Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis. Experimental Parasitology 199, pages 30-37.
Crossref
Crossref
Karen C. Rangel, Hosana M. Debonsi, Leandro C. Clementino, Márcia A. S. Graminha, Leonardo Z. Vilela, Pio Colepicolo & Lorena R. Gaspar. (2018) Antileishmanial activity of the Antarctic red algae Iridaea cordata (Gigartinaceae; Rhodophyta). Journal of Applied Phycology 31:2, pages 825-834.
Crossref
Crossref
Jacques Leañez, Jorge Nuñez, Yael García-Marchan, Felipe Sojo, Francisco Arvelo, Daniel Rodriguez, Ignacio Buscema, Alvaro Alvarez-Aular, Josué S. Bello Forero, Vladímir V. Kouznetsov & Xenón Serrano-Martín. (2019) Anti-leishmanial effect of spiro dihydroquinoline-oxindoles on volume regulation decrease and sterol biosynthesis of Leishmania braziliensis. Experimental Parasitology 198, pages 31-38.
Crossref
Crossref
Asmita Pramanik, Dibyendu Paik, Pijush Kanti Pramanik & Tapati Chakraborti. (2019) Serine protease inhibitors rich Coccinia grandis (L.) Voigt leaf extract induces protective immune responses in murine visceral leishmaniasis. Biomedicine & Pharmacotherapy 111, pages 224-235.
Crossref
Crossref
Grasiele S.V. Tavares, Débora V.C. Mendonça, Daniela P. Lage, Luciana M.R. Antinarelli, Tauane G. Soyer, Ana J.S. Senna, Guilherme F. Matos, Daniel S. Dias, Patrícia A.F. Ribeiro, João P.T. Batista, Joana M. Poletto, Geraldo C. Brandão, Miguel A. Chávez-Fumagalli, Guilherme R. Pereira, Elaine S. Coimbra & Eduardo A.F. Coelho. (2019) In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species. Acta Tropica 191, pages 29-37.
Crossref
Crossref
Grace Cuddihy, Ellen Wasan, Yunyun Di & Kishor Wasan. (2019) The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?. Pharmaceutics 11:3, pages 99.
Crossref
Crossref
Raquel Álvarez-Velilla, Maria del Camino Gutiérrez-Corbo, Carmen Punzón, Maria Yolanda Pérez-Pertejo, Rafael Balaña-Fouce, Manuel Fresno & Rosa María Reguera. (2019) A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery. PLOS Neglected Tropical Diseases 13:2, pages e0007133.
Crossref
Crossref
Sarah L. Berry, Karen Walker, Clare Hoskins, Neil D. Telling & Helen P. Price. (2019) Nanoparticle-mediated magnetic hyperthermia is an effective method for killing the human-infective protozoan parasite Leishmania mexicana in vitro. Scientific Reports 9:1.
Crossref
Crossref
Flávio R. Nóbrega, Larisse V. Silva, Carlos da Silva M. Bezerra Filho, Tamires C. Lima, Yunierkis P. Castillo, Daniel P. Bezerra, Tatjana K. Souza Lima & Damião P. de Sousa. (2019) Design, Antileishmanial Activity, and QSAR Studies of a Series of Piplartine Analogues. Journal of Chemistry 2019, pages 1-12.
Crossref
Crossref
Samanta Etel Treiger Borborema, João Alberto Osso Junior, Heitor Franco de Andrade Junior & Nanci do Nascimento. (2019) Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice. Journal of Venomous Animals and Toxins including Tropical Diseases 25.
Crossref
Crossref
Carine Santana Ferreira Marques, Jorge Barreto Machado Júnior, Lucas Rannier de Melo Andrade, Luciana Nalone Andrade, André Luis Souza dos Santos, Maria do Socorro Pires e Cruz, Marco Chaud, Alini Tinoco Fricks & Patrícia Severino. (2019) Use of pharmaceutical nanotechnology for the treatment of leishmaniasis. Revista da Sociedade Brasileira de Medicina Tropical 52.
Crossref
Crossref
Ariane de Jesus Sousa-Batista, Cristal Cerqueira-Coutinho, Fagner Santos do Carmo, Marta de Souza Albernaz & Ralph Santos-Oliveira. (2019) Polycaprolactone Antimony Nanoparticles as Drug Delivery System for Leishmaniasis. American Journal of Therapeutics 26:1, pages e12-e17.
Crossref
Crossref
Ashok Aspatwar, Harlan Barker, Martti Tolvanen, Reza Zolfaghari Emameh & Seppo Parkkila. 2019. Carbonic Anhydrases. Carbonic Anhydrases
449
475
.
Christopher Fernández-Prada, Noelie Douanne, Aida Minguez-Menendez, Joan Pena, Luiza G. Tunes, Douglas E.V. Pires & Rubens L. Monte-Neto. 2019. In Silico Drug Design. In Silico Drug Design
119
160
.
Vladimir V. Kouznetsov, Carlos M. Meléndez Gómez, José Luis Valencia Peña & Leonor Y. Vargas-Méndez. 2019. Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases. Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases
87
164
.
Nasib Singh, Pooja Devi Gautam, Puja Kumari Chauhan, Tanvir Kaur, Karan Singh, Joginder Singh & Sumit Singh Dagar. 2019. Pharmaceuticals from Microbes. Pharmaceuticals from Microbes
27
47
.
Prabin Kumar, Pragya Misra, Abhinav Saurabh, Narayan Rishi & Dipendra Kumar Mitra. (2018) Adjunct Therapy of rIFN-g and rIL-17A along with Sub-optimal Dose of Amphotericin-B effectively Control the Leishmania donovani Parasitic Growth in Infected Mice. Journal of Pure and Applied Microbiology 12:4, pages 1771-1782.
Crossref
Crossref
Simone S Grecco, Thais A Costa-Silva, Fernanda S Sousa, Stefano B Cargnelutti, Eric Umehara, Poliana S Mendonça, Andre G Tempone & Joao Henrique G Lago. (2018) Neolignans isolated from twigs of Nectandra leucantha Ness & Mart (Lauraceae) displayed in vitro antileishmanial activity. Journal of Venomous Animals and Toxins including Tropical Diseases 24:1.
Crossref
Crossref
Md Golam Hasnain, Proggananda Nath, Shomik Maruf, Shah Golam Nabi, A. F. M. Akhtar Hossain, Be-Nazir Ahmed, Dinesh Mondal & Ariful Basher. (2018) Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study. BMC Research Notes 11:1.
Crossref
Crossref
Sujit K. Bhattacharya, Ajanta Ghosal, Sudeshna Ganguly, Sandipan Ganguly, Sabahat Azim & Shanta Dutta. 2018. Leishmaniases as Re-emerging Diseases. Leishmaniases as Re-emerging Diseases.
Renata Mondêgo de Oliveira, Solange de Araújo Melo, Tatiane Aranha da Penha-Silva, Fernando Almeida-Souza & Ana Lucia Abreu-Silva. 2018. Leishmaniases as Re-emerging Diseases. Leishmaniases as Re-emerging Diseases.
Ariane Sousa-Batista & Bartira Rossi-Bergmann. 2018. Leishmaniases as Re-emerging Diseases. Leishmaniases as Re-emerging Diseases.
Raísha Costa Martins, Gilson Pires Dorneles, Vivian Oliveira Nunes Teixeira, Ana Maria Antonello, Júlia Lacerda Couto, Luiz Carlos Rodrigues Júnior, Marta Chagas Monteiro, Alessandra Peres, Henri Stephan Schrekker & Pedro Roosevelt Torres Romão. (2018) Imidazolium salts as innovative agents against Leishmania amazonensis. International Immunopharmacology 63, pages 101-109.
Crossref
Crossref
A. Oryan, E. Bemani & S. Bahrami. (2018) Emerging role of amiodarone and dronedarone, as antiarrhythmic drugs, in treatment of leishmaniasis. Acta Tropica 185, pages 34-41.
Crossref
Crossref
Kelly C. Kato, Eliane de Morais-Teixeira, Arshad Islam, M. Fatima Leite, Cynthia Demicheli, Whocely V. de Castro, José D. Corrêa-Junior, Ana Rabello & Frédéric Frézard. (2018) Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis. Antimicrobial Agents and Chemotherapy 62:8.
Crossref
Crossref
Cristina de Castro Spadari, Taissa Vila, Sonia Rozental & Kelly Ishida. (2018) Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts. Antimicrobial Agents and Chemotherapy 62:8.
Crossref
Crossref
Bruna Taciane da Silva Bortoleti, Manoela Daiele Gonçalves, Fernanda Tomiotto-Pellissier, Milena Menegazzo Miranda-Sapla, João Paulo Assolini, Amanda Cristina Machado Carloto, Priscila Goes Camargo de Carvalho, Ian Lucas Alves Cardoso, Andréa Name Colado Simão, Nilton Syogo Arakawa, Idessania Nazareth Costa, Ivete Conchon-Costa & Wander Rogério Pavanelli. (2018) Grandiflorenic acid promotes death of promastigotes via apoptosis-like mechanism and affects amastigotes by increasing total iron bound capacity. Phytomedicine 46, pages 11-20.
Crossref
Crossref
Elizabeth Valdivieso, Fabiola Mejías, Carlos Torrealba, Gustavo Benaim, Vladimir V. Kouznetsov, Felipe Sojo, Fernando A. Rojas-Ruiz, Francisco Arvelo & Francehuli Dagger. (2018) In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption. Acta Tropica 183, pages 36-42.
Crossref
Crossref
Angela ToeppMandy LarsonTara Grinnage-PulleyCarolyne BennettMichael AndersonMolly ParrishHailie FowlerGeneva WilsonKatherine Gibson-CorelyRadhika Gharpure, Caitlin Cotter & Christine Petersen. (2018) Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial. The American Journal of Tropical Medicine and Hygiene 98:5, pages 1332-1338.
Crossref
Crossref
Ana Tejería, Yolanda Pérez-Pertejo, Rosa M. Reguera, Rafael Balaña-Fouce, Concepción Alonso, María González, Gloria Rubiales & Francisco Palacios. (2018) Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation. European Journal of Medicinal Chemistry 152, pages 137-147.
Crossref
Crossref
SHYAM SUNDAR & ANUP SINGH. (2017) Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology 145:4, pages 481-489.
Crossref
Crossref
João Gabriel Guimarães Luz, Danilo Bueno Naves, Amanda Gabriela de Carvalho, Gilvani Alves Meira, João Victor Leite Dias & Cor Jesus Fernandes Fontes. (2018) Visceral leishmaniasis in a Brazilian endemic area: an overview of occurrence, HIV coinfection and lethality. Revista do Instituto de Medicina Tropical de São Paulo 60:0.
Crossref
Crossref
Ariane de Jesus Sousa-Batista, Wallace Pacienza-Lima, Natalia Arruda-Costa, Camila Alves Bandeira Falcão, Maria Ines Ré & Bartira Rossi-Bergmann. (2018) Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy 62:3.
Crossref
Crossref
Débora V.C. Mendonça, Vívian T. Martins, Daniela P. Lage, Daniel S. Dias, Patrícia A.F. Ribeiro, Ana Maria R.S. Carvalho, Anna Letícia T. Dias, Carolina K. Miyazaki, Daniel Menezes-Souza, Bruno M. Roatt, Carlos A.P. Tavares, José Mário Barichello, Mariana C. Duarte & Eduardo A.F. Coelho. (2018) Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis. Experimental Parasitology 186, pages 24-35.
Crossref
Crossref
Wanessa Trindade Clemente, Paulo Henrique Orlandi Mourão, Francisco Lopez-Medrano, Brian S. Schwartz, Carmen García-Donoso & Julian Torre-Cisneros. (2018) Visceral and Cutaneous Leishmaniasis Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation 102:2S, pages S8-S15.
Crossref
Crossref
REBECCA L. CHARLTON, BARTIRA ROSSI-BERGMANN, PAUL W. DENNY & PATRICK G. STEEL. (2017) Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art. Parasitology 145:2, pages 219-236.
Crossref
Crossref
April C. Joice, Sihyung Yang, Abdelbasset A. Farahat, Heidi Meeds, Mei Feng, Junan Li, David W. Boykin, Michael Zhuo Wang & Karl A. Werbovetz. (2018) Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations. Antimicrobial Agents and Chemotherapy 62:1.
Crossref
Crossref
Sarah Hendrickx, Louis Maes, Simon L. Croft & Guy Caljon. 2018. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
193
206
.
Shyam Sundar & Jaya Chakravarty. 2018. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
159
176
.
Badriah Alkathiri, Manal El-Khadragy, Dina Metwally, Ebtesam Al-Olayan, Muhammed Bakhrebah & Ahmed Abdel Moneim. (2017) Pomegranate (Punica granatum) Juice Shows Antioxidant Activity against Cutaneous Leishmaniasis-Induced Oxidative Stress in Female BALB/c Mice. International Journal of Environmental Research and Public Health 14:12, pages 1592.
Crossref
Crossref
Anna Eichenberger, Annina E. Buechi, Andreas Neumayr, Chistroph Hatz, Andri Rauch, Marc Huguenot, Eva Diamantis-Karamitopoulou & Cornelia Staehelin. (2017) A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure. BMC Infectious Diseases 17:1.
Crossref
Crossref
Jorge Enrique Machado-Alba, Manuel E. Machado-Duque & Diego Alejandro Medina-Morales. (2017) Epidemiology of Cutaneous Leishmaniasis in a Colombian Municipality. The American Journal of Tropical Medicine and Hygiene 97:5, pages 1503-1507.
Crossref
Crossref
Stefânia N. Lavorato, Mariana C. Duarte, Daniela P. Lage, Carlos A. P. Tavares, Eduardo A. F. Coelho & Ricardo J. Alves. (2017) 1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents. Chemical Biology & Drug Design 90:5, pages 981-986.
Crossref
Crossref
Annelies Mondelaers, Sarah Hendrickx, Guy Caljon & Louis Maes. 2017. Drug Discovery for Leishmaniasis. Drug Discovery for Leishmaniasis
371
386
.
A. J. SOUSA-BATISTA, F. S. POLETTO, C. I. M. S. PHILIPON, S. S. GUTERRES, A. R. POHLMANN & B. ROSSI-BERGMANN. (2017) Lipid-core nanocapsules increase the oral efficacy of quercetin in cutaneous leishmaniasis. Parasitology 144:13, pages 1769-1774.
Crossref
Crossref
Katia Fialho Nascimento, Fabiana Rodrigues de Santana, Cleber Rafael Vieira da Costa, Vanessa Kaplum, Helito Volpato, Celso Vaturo Nakamura, Leoni Villano Bonamin & Dorly de Freitas Buchi. (2017) M1 homeopathic complex trigger effective responses against Leishmania (L) amazonensis in vivo and in vitro. Cytokine 99, pages 80-90.
Crossref
Crossref
Bilal Zulfiqar, Amy Jones, Melissa Sykes, Todd Shelper, Rohan Davis & Vicky Avery. (2017) Screening a Natural Product-Based Library against Kinetoplastid Parasites. Molecules 22:10, pages 1715.
Crossref
Crossref
Bilal Zulfiqar, Todd B. Shelper & Vicky M. Avery. (2017) Leishmaniasis drug discovery: recent progress and challenges in assay development. Drug Discovery Today 22:10, pages 1516-1531.
Crossref
Crossref
Jacob T. Bush, Monique Wasunna, Fabiana Alves, Jorge Alvar, Piero L. Olliaro, Michael Otieno, Carol Hopkins Sibley, Nathalie Strub Wourgaft & Philippe J. Guerin. (2017) Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform. PLOS Neglected Tropical Diseases 11:9, pages e0005781.
Crossref
Crossref
N. ARRUDA-COSTA, D. ESCRIVANI, E. E. ALMEIDA-AMARAL, J. R. MEYER-FERNANDES & B. ROSSI-BERGMANN. (2017)
Anti-parasitic effect of the diuretic and Na
+
-ATPAse inhibitor furosemide in cutaneous leishmaniasis
. Parasitology 144:10, pages 1375-1383.
Crossref
Crossref
Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Scott G. Franzblau, Baojie Wan, Yuehong Wang, Zhenkun Ma, Christopher B. Cooper & William A. Denny. (2017)
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-
b
][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis
. Journal of Medicinal Chemistry 60:10, pages 4212-4233.
Crossref
Crossref
Stefânia N. Lavorato, Mariana C. Duarte, Daniela P. Lage, Carlos A. P. Tavares, Eduardo A. F. Coelho & Ricardo J. Alves. (2017) Synthesis and antileishmanial activity of 1,3-bis(aryloxy)propan-2-amines. Medicinal Chemistry Research 26:5, pages 1052-1072.
Crossref
Crossref
Ming Jang Chua, Megan S.J. Arnold, Weijun Xu, Julien Lancelot, Suzanne Lamotte, Gerald F. Späth, Eric Prina, Raymond J. Pierce, David P. Fairlie, Tina S. Skinner-Adams & Katherine T. Andrews. (2017) Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth. International Journal for Parasitology: Drugs and Drug Resistance 7:1, pages 42-50.
Crossref
Crossref
Diego Conrado Pereira Rossi, Cristina de Castro Spadari, Joshua Daniel Nosanchuk, Carlos Pelleschi Taborda & Kelly Ishida. (2017) Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation. International Journal of Antimicrobial Agents 49:4, pages 465-471.
Crossref
Crossref
Fabiana Rodrigues de Santana, Luciane C. Dalboni, Kátia F. Nascimento, Fabiana Toshie Konno, Anuska M. Alvares-Saraiva, Michelle S.F. Correia, Maristela Dutra Correa Bomfim, Renato C.V. Casarin, Elizabeth C. Perez, Maria Anete Lallo, Giovani B. Peres, Márcia Dalastra Laurenti, Nilson R. Benites, Dorly F. Buchi & Leoni Villano Bonamin. (2017) High dilutions of antimony modulate cytokines production and macrophage – Leishmania (L.) amazonensis interaction in vitro. Cytokine 92, pages 33-47.
Crossref
Crossref
Alane B. Vermelho, Giseli R. Capaci, Igor A. Rodrigues, Verônica S. Cardoso, Ana Maria Mazotto & Claudiu T. Supuran. (2017) Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets. Bioorganic & Medicinal Chemistry 25:5, pages 1543-1555.
Crossref
Crossref
Forough Khadem, Ping Jia, Zhirong Mou, Aida Feiz Barazandeh, Dong Liu, Yoav Keynan & Jude E. Uzonna. (2017) Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis. Journal of Antimicrobial Chemotherapy 72:2, pages 467-477.
Crossref
Crossref
L. Maes, J. Beyers, A. Mondelaers, M. Van den Kerkhof, E. Eberhardt, G. Caljon & S. Hendrickx. (2017)
In vitro
‘time-to-kill’ assay to assess the cidal activity dynamics of current reference drugs against
Leishmania donovani
and
Leishmania infantum
. Journal of Antimicrobial Chemotherapy 72:2, pages 428-430.
Crossref
Crossref
Larissa Catharina, Carlyle Ribeiro Lima, Alexander Franca, Ana Carolina Ramos Guimarães, Marcelo Alves-Ferreira, Pierre Tuffery, Philippe Derreumaux & Nicolas Carels. (2017)
A Computational Methodology to Overcome the Challenges Associated With the Search for Specific Enzyme Targets to Develop Drugs Against
Leishmania major
. Bioinformatics and Biology Insights 11, pages 117793221771247.
Crossref
Crossref
Peter Mbugua Njogu, John Okombo & Kelly Chibale. 2017. Design of Hybrid Molecules for Drug Development. Design of Hybrid Molecules for Drug Development
83
135
.
Shyam Sundar & Jaya Chakravarty. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
1293
1304
.
Kiran Motaparthi. 2017. Therapy in Pediatric Dermatology. Therapy in Pediatric Dermatology
249
252
.
Christopher Fernandez-Prada, Isabel M. Vincent, Marie-Christine Brotherton, Mathew Roberts, Gaétan Roy, Luis Rivas, Philippe Leprohon, Terry K. Smith & Marc Ouellette. (2016) Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms. PLOS Neglected Tropical Diseases 10:12, pages e0005171.
Crossref
Crossref
Andreia Vieira Pereira, Gustavo de Barros, Erika Gracielle Pinto, Andre Gustavo Tempone, Ricardo de Oliveira Orsi, Lucilene Delazari dos Santos, Sueli Calvi, Rui Seabra Ferreira, Daniel Carvalho Pimenta & Benedito Barraviera. (2016) Melittin induces in vitro death of Leishmania (Leishmania) infantum by triggering the cellular innate immune response. Journal of Venomous Animals and Toxins including Tropical Diseases 22:1.
Crossref
Crossref
Om Prakash Singh, Bhawana Singh, Jaya Chakravarty & Shyam Sundar. (2016) Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective. Infectious Diseases of Poverty 5:1.
Crossref
Crossref
Adriana Bezerra-Souza, Eduardo S. Yamamoto, Márcia D. Laurenti, Susan P. Ribeiro & Luiz Felipe D. Passero. (2016) The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Parasitology International 65:6, pages 702-707.
Crossref
Crossref
S. Gabriel Renata, Claudia F. Amaral Ana, Corte-Real Suzana, C. Lopes Rosana, S. Alviano Celuta, B. Vermelho Alane, S. Alviano Daniela & A. Rodrigues Igor. (2016) Antileishmanial effects of the alkaloid-rich fraction of Quassia amara L.. Journal of Medicinal Plants Research 10:42, pages 775-782.
Crossref
Crossref
M. Heidari-Kharaji, T. Taheri, D. Doroud, S. Habibzadeh, A. Badirzadeh & S. Rafati. (2016)
Enhanced paromomycin efficacy by solid lipid nanoparticle formulation against
Leishmania
in mice model
. Parasite Immunology 38:10, pages 599-608.
Crossref
Crossref
Carolina S. Lopes, Nada Daifalla, Bikul Das, Valdo Dias da Silva & Antonio Campos-Neto. (2016) CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum. PLOS ONE 11:9, pages e0162927.
Crossref
Crossref
Shilpi Khare, Advait S. Nagle, Agnes Biggart, Yin H. Lai, Fang Liang, Lauren C. Davis, S. Whitney Barnes, Casey J. N. Mathison, Elmarie Myburgh, Mu-Yun Gao, J. Robert Gillespie, Xianzhong Liu, Jocelyn L. Tan, Monique Stinson, Ianne C. Rivera, Jaime Ballard, Vince Yeh, Todd Groessl, Glenn Federe, Hazel X. Y. Koh, John D. Venable, Badry Bursulaya, Michael Shapiro, Pranab K. Mishra, Glen Spraggon, Ansgar Brock, Jeremy C. Mottram, Frederick S. Buckner, Srinivasa P. S. Rao, Ben G. Wen, John R. Walker, Tove Tuntland, Valentina Molteni, Richard J. Glynne & Frantisek Supek. (2016) Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. Nature 537:7619, pages 229-233.
Crossref
Crossref
Alan H. Fairlamb, Neil A. R. Gow, Keith R. Matthews & Andrew P. Waters. (2016) Drug resistance in eukaryotic microorganisms. Nature Microbiology 1:7.
Crossref
Crossref
Grégory Michel, Bernard Ferrua, Patrick Munro, Laurent Boyer, Nassim Mathal, Daniel Gillet, Pierre Marty & Emmanuel Lemichez. (2016) Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum. PLOS ONE 11:6, pages e0156363.
Crossref
Crossref
Shyam Sundar & Anup Singh. (2016) Recent developments and future prospects in the treatment of visceral leishmaniasis. Therapeutic Advances in Infectious Disease 3:3-4, pages 98-109.
Crossref
Crossref
Tina S. Skinner-Adams, Subathdrage D.M. Sumanadasa, Gillian M. Fisher, Rohan A. Davis, Denise L. Doolan & Katherine T. Andrews. (2016) Defining the targets of antiparasitic compounds. Drug Discovery Today 21:5, pages 725-739.
Crossref
Crossref
Annelies Mondelaers, Maria P. Sanchez-Cañete, Sarah Hendrickx, Eline Eberhardt, Raquel Garcia-Hernandez, Laurence Lachaud, James Cotton, Mandy Sanders, Bart Cuypers, Hideo Imamura, Jean-Claude Dujardin, Peter Delputte, Paul Cos, Guy Caljon, Francisco Gamarro, Santiago Castanys & Louis Maes. (2016) Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes. PLOS ONE 11:4, pages e0154101.
Crossref
Crossref
Hideo Imamura, Tim Downing, Frederik Van den Broeck, Mandy J Sanders, Suman Rijal, Shyam Sundar, An Mannaert, Manu Vanaerschot, Maya Berg, Géraldine De Muylder, Franck Dumetz, Bart Cuypers, Ilse Maes, Malgorzata Domagalska, Saskia Decuypere, Keshav Rai, Surendra Uranw, Narayan Raj Bhattarai, Basudha Khanal, Vijay Kumar Prajapati, Smriti Sharma, Olivia Stark, Gabriele Schönian, Harry P De Koning, Luca Settimo, Benoit Vanhollebeke, Syamal Roy, Bart Ostyn, Marleen Boelaert, Louis Maes, Matthew Berriman, Jean-Claude Dujardin & James A Cotton. (2016) Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent. eLife 5.
Crossref
Crossref
Namrata Sharma, Neelima Aron, Tushar Agarwal & Charu Sharma. 2016. Pharmacology of Ocular Therapeutics. Pharmacology of Ocular Therapeutics
285
332
.
Kei Katsuno, Jeremy N. Burrows, Ken Duncan, Rob Hooft van Huijsduijnen, Takushi Kaneko, Kiyoshi Kita, Charles E. Mowbray, Dennis Schmatz, Peter Warner & B. T. Slingsby. (2015) Hit and lead criteria in drug discovery for infectious diseases of the developing world. Nature Reviews Drug Discovery 14:11, pages 751-758.
Crossref
Crossref
Audrey Romano, Nicole A. Doria, Jonatan Mendez, David L. Sacks & Nathan C. Peters. (2015)
Cutaneous Infection with
Leishmania major
Mediates Heterologous Protection against Visceral Infection with
Leishmania infantum
. The Journal of Immunology 195:8, pages 3816-3827.
Crossref
Crossref
Eugene M. Tan, Jasmine R. Marcelin & Abinash Virk. (2015) A 24-Year-Old Traveler With an Insect Bite and Rash: Figure 1.. Clinical Infectious Diseases 61:8, pages 1342-1343.
Crossref
Crossref
Igor A. Rodrigues, Ana Maria Mazotto, Verônica Cardoso, Renan L. Alves, Ana Claudia F. Amaral, Jefferson Rocha de Andrade Silva, Anderson S. Pinheiro & Alane B. Vermelho. (2015) Natural Products: Insights into Leishmaniasis Inflammatory Response. Mediators of Inflammation 2015, pages 1-12.
Crossref
Crossref